Clément BERTHOLET

About

Clément Bertholet joined AdBio Partners in September 2021 as an operational investor, was promoted to Partner in 2023, and to Managing Partner in 2025. He brings expertise in financial negotiations and knowledge of the public sector, complementing his academic background in molecular biology. Clément was involved in the initial development of Thabor Therapeutics before co-founding and leading Calida Therapeutics in the field of thrombo-inflammation, based on a US technology re-located to France. Previously, Clément was deputy governmental delegate for business restructuring, reporting to the Ministers in charge of Economy and Finance, Industry, and Labor. Prior to this, Clément held several positions at the French Treasury, BNP Paribas, CIB New York and GDF Suez. Before joining the Corps des Mines training program, Clément had a background in biology with several internships in epigenetics at the Institut Curie and Cancer Research UK.